|Former Common name||SMD, BALB-smd|
|H-2 Haplotype||No Data|
|Background strain||No Data|
|Strain development||Developed by Yoshibumi Matsushima, Saitama Cancer Center, Research Institute for Clinical Oncology. BALB/cNCrSlc background (semicongenic).|
|Strain description||Spontaneous muscular dystrophy (SMD) mice. Autosomal recessive mutant arose in BALB/c. Homozygous mutant mice show muscular dystrophy, survive for up to about 2-5 months old. Under investigation.|
|Colony maintenance||Heterozygote x Heterozygote [or Homozygote (female) x Heterozygote (male)(Transplant-Cross-Intercross)][or Crossing to BALB/cCrSlc]|
|Symbol name||spontaneous muscular dystrophy|
|Common name||No Data|
|Symbol description||No Data|
|Research applications||Mouse Models for Human Disease,
|Specific Term and Conditions||The following terms and conditions will be requested by the DEPOSITOR.
In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.
後日指定。(will be announced.)
For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR.
|Depositor||Matsushima, Yoshibumi (Saitama Cancer Center)|
|Strain Status /